+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ventricular Assist Device Market - Forecasts from 2019 to 2024

  • PDF Icon

    Report

  • 108 Pages
  • October 2019
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 4858202
The ventricular assist device market is projected to grow at a CAGR of 10.32% to reach US$2,360.213 million by 2024, from US$1,309.259 million in 2018. Rising prevalence of cardiovascular diseases and an enormous gap between the demand and supply of donor's hearts are the prime factors for driving the growth of the market. According to World Health Organization report nearly 17.9 million people around the globe die because of cardiovascular disease every year, which accounts 31% of all deaths. Moreover increasing number of regulatory approvals also acts as a driving factor for the growth of the market. However high cost of ventricular assist devices along with the high cost of implantation works as the restraining factor for the growth of the market.

The “Ventricular Assist Device Market - Forecasts from 2019 to 2024” is an exhaustive study which aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, application, and geography.

The ventricular assist device market has been segmented based on type, application, and geography. By type the market is segmented into left ventricular assist device (LVAD), right ventricular assist device (RVAD), and bi-Ventricular Assist Device (BVAD). By application, the market is segmented Bridge-To-Candidacy (BTC), Bridge-To-Transplant (BTT), and Destination Therapy (DT).

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes 15 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in the ventricular assist device market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in the ventricular assist device market.

Segmentation

The ventricular assist device market has been analyzed through following segments:

By Type
  • Left ventricular assist device (LVAD)
  • Right ventricular assist device (RVAD)
  • Bi-Ventricular Assist Device (BVAD)

By Application
  • Bridge-To-Candidacy (BTC)
  • Bridge-To-Transplant (BTT)
  • Destination Therapy (DT)

By Geography

North America
  • United States
  • Canada
  • Mexico

South America
  • Brazil
  • Argentina
  • Others

Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others

Middle East and Africa
  • Saudi Arabia
  • Israel
  • Others

Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Others

Table of Contents

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. VENTRICULAR ASSIST DEVICE MARKET BY TYPE
5.1. Left ventricular assist device (LVAD)
5.2. Right ventricular assist device (RVAD)
5.3. Bi-Ventricular Assist Device (BVAD)
6. VENTRICULAR ASSIST DEVICE MARKET BY APPLICATION
6.1. Bridge-To-Candidacy (BTC)
6.2. Bridge-To-Transplant (BTT)
6.3. Destination Therapy (DT)
7. VENTRICULAR ASSIST DEVICE MARKET BY GEOGRAPHY
7.1. North America
7.1.1. United States
7.1.2. Canada
7.1.3. Mexico
7.2. South America
7.2.1. Brazil
7.2.2. Argentina
7.2.3. Others
7.3. Europe
7.3.1. United Kingdom
7.3.2. Germany
7.3.3. France
7.3.4. Italy
7.3.5. Others
7.4. Middle East and Africa
7.4.1. Saudi Arabia
7.4.2. Israel
7.4.3. Others
7.5. Asia Pacific
7.5.1. China
7.5.2. Japan
7.5.3. India
7.5.4. South Korea
7.5.5. Others
8. COMPETITIVE INTELLIGENCE
8.1. Competitive Benchmarking and Analysis
8.2. Recent Investments and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Medtronic
9.2. Abbott Laboratories
9.3. Jarvik Heart
9.4. Reliantheart
9.5. Berlin Heart

Companies Mentioned

  • Medtronic
  • Abbott Laboratories
  • Jarvik Heart
  • Reliantheart
  • Berlin Heart